Cannava is the leading state-owned company in Argentina dedicated to producing medicinal cannabis derivatives. Founded with the support of the Jujuy provincial government, Cannava is fully committed to a 100% Jujuyan and Argentinean production process. With a focus on bringing specialty medicinal cannabis derived products from the land to the patient, they adhere to the highest standards of quality and traceability required by the pharmaceutical industry.

Their production follows organic agricultural practices, and they have a specialized biotechnology complex for the production of active pharmaceutical ingredients derived from the plant. Cannava offers a range of products and services, including agricultural production, pharmaceutical industrial processing, scientific research, and institutional strengthening. They are actively involved in several research projects aimed at exploring the scientific and medicinal potential of cannabis and its derivatives for the treatment of various conditions.

Additionally, Cannava has developed the first clinical management guide for medicinal cannabis in Argentina. They prioritize transparency and communication, regularly sharing news and informative reports. Furthermore, Cannava has expanded its reach internationally by exporting finished products to Switzerland and Germany, positioning themselves as a global player in the international supply chain